Hiydrow (HY-1)
Hiydrow is named after one of the UK’s most prolific caregivers and cannabis campaigners. This powerful CBD:THC 1.5:1 strain is has been developed for medical use. Hiydrow himself is a PTSD and chronic pain sufferer and his insight has been invaluable in creating this special strain.
Breeder: MM Genetics
Genetics: CD-1 x Girl Scout Cookies
Variety: Mostly Indica
THC Content: High
CBD Content: High
CBD to THC ratio: 1.5:1
Sex: Feminised
Flowering Time: 8-9 Weeks
Yield: Medium
Medicinal Use: Chronic Pain, Muscle Spasms, Nausea, Vomiting, Fibromyalgia, Multiple Sclerosis, Lupus
Hiydrow (HY-1) is suitable for use throughout the day and night and can help with a number of common ailments including chronic pain, anxiety, depression, fatigue and more.
In 2014, the founders of MM Genetics witnessed the therapeutic nature of cannabis while treating a founder’s mother. Candida Green was battling late-stage pancreatic cancer. Hours after her first dose of cannabis oil her pain was significantly reduced and in the following weeks, her quality of life dramatically improved.
The website medicalmarijuana.co.uk was set up shortly after her death with the simple aim of raising awareness of the real medicinal properties of the Cannabis Sativa L plant.
The benefits of the cannabis oil were clearly visible to those around her and awoke a passion and deep interest in the use of cannabis as a medicine. A concept to source and sell seeds with exciting therapeutic benefits was developed while raising awareness in local communities.
Through the organisation’s interaction with patients and cannabis communities worldwide, it quickly became apparent that the need was for cannabis genetics that targeted specific symptoms.
Medical Marijuana Genetics was formed in 2015 and began working with award-winning breeders and caregivers. A line of CBD dominant cannabis strains has since been created and has gone on to win several awards including best CBD strain at Spannabis 2017. These CBD cannabis seeds are now available here.
The laboratory tests of our flagship strain, Candida, revealed a CBD count of 20% with a THC count of under 1%. This percentage is the highest known count in a CBD-rich phenotype ever created in Europe.
Following the overwhelming success of their first grow, Medical Marijuana Genetics created a further 12 elite strains from Candida crosses, all of which have been genetically selected to provide access (within the lawful jurisdiction) to the broadest range of therapeutics that the cannabis plant, and CBD in particular, has to offer. This includes treatments for symptoms such chronic pain, inflammation, seizures, convulsions, gastrointestinal disorders, nausea, vomiting, skin conditions, bacterial infections, anxiety, depression, cancer cell growth and much more.